EVELIQURE BIOTECHNOLOGIES GMBH
WIEN, WIEN 1030
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541715 | $8.37M | 12 |
Contract Awards
5 awards found
TO ADVANCE THE DEVELOPMENT OF THE SHIGETEC VACCINE THROUGH CGMP MANUFACTURING AND RELEASE OF ADDITIONAL CGMP LOTS FOR USE IN A SERIES OF PHASE 2 CLINICAL TRIALS.
TO ADVANCE THE DEVELOPMENT OF THE SHIGETEC VACCINE THROUGH CGMP MANUFACTURING AND RELEASE OF ADDITIONAL CGMP LOTS FOR USE IN A SERIES OF PHASE 2 CLINICAL TRIALS.
TO ADVANCE THE DEVELOPMENT OF THE SHIGETEC VACCINE THROUGH CGMP MANUFACTURING AND RELEASE OF ADDITIONAL CGMP LOTS FOR USE IN A SERIES OF PHASE 2 CLINICAL TRIALS.
TO ADVANCE THE DEVELOPMENT OF THE SHIGETEC VACCINE THROUGH CGMP MANUFACTURING AND RELEASE OF ADDITIONAL CGMP LOTS FOR USE IN A SERIES OF PHASE 2 CLINICAL TRIALS.
TO ADVANCE THE DEVELOPMENT OF THE SHIGETEC VACCINE THROUGH CGMP MANUFACTURING AND RELEASE OF ADDITIONAL CGMP LOTS FOR USE IN A SERIES OF PHASE 2 CLINICAL TRIALS.
Business Details
- UEI
- ZKEJW1JEKBQ9
- CAGE Code
- 6311N
- Address
- KARL-FARKAS-GASSE 22
WIEN, 1030
Parent Company
EVELIQURE BIOTECHNOLOGIES GMBH
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov